An orthogonal T7 replisome for continuous hypermutation and accelerated evolution in <i>E. coli</i>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40773556.
- Also identified by DOI 10.1126/science.adp9583.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Systems that perform continuous hypermutation of designated genes without compromising the integrity of the host genome can substantially accelerate the evolution of new or enhanced protein functions. We describe an orthogonal DNA replication system in <i>Escherichia coli</i> based on the controlled expression of the replisome of bacteriophage T7 (T7-ORACLE). The system replicates circular plasmids that enable high transformation efficiencies and seamless integration into standard molecular biology workflows. Engineering of T7 DNA polymerase yielded variant proteins with mutation rates of 1.7 × 10<sup>-5</sup> substitutions per base in vivo-100,000-fold above the genomic mutation rate. We demonstrated continuous evolution using the T7 replisome by expanding the substrate scope of TEM-1 β-lactamase and increasing activity 5000-fold against clinically relevant monobactam and cephalosporin antibiotics in less than 1 week.
Medical subject headings
- Bacteriophage T7
- Directed Molecular Evolution
- DNA Replication
- DNA-Directed DNA Polymerase
- Escherichia coli
- Multienzyme Complexes
- Protein Engineering
- Viral Proteins
- DNA-Directed RNA Polymerases